Innovative Medicines Initiative 2.0 - 13. Call
Das IMI Office hielt zu jedem Topic ein Webinar ab. Zwei weitere Webinare hatten „IMI Rules and Procedures“ bzw. „IMI2 Call 13 – Opportunities for SMEs“ zum Inhalt. Die Aufzeichnungen und Präsentationen der Webinare finden Sie hier.
Folgende Topics werden im Rahmen des 13. Calls von IMI2 ausgeschrieben:
Topic 1: Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches
Topic 2: Genome-environment interactions in inflammatory skin disease
Topic 3: The value of diagnostics to combat antimicrobial resistance by optimising antibiotic use
Topic 4: Mitochondrial dysfunction in neurodegeneration
Topic 5: Support and coordination action for the projects of the neurodegeneration area of the Innovative Medicines Initiative
Topic 6: A sustainable European induced pluripotent stem cell platform
Topic 7: Linking digital assessment of mobility to clinical endpoints to drive regulatory acceptance and clinical practice
Topic 8: Human tumour microenvironment immunoprofiling
Topic 9: CONCEPTION – continuum of evidence from pregnancy exposures, reproductive toxicology and breastfeeding to improve outcomes now
Topic 10: Improving the preclinical prediction of adverse effects of pharmaceuticals on the nervous system
Topic 11: Translational safety biomarker pipeline (TRANSBIOLINE): enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
Topic 12: Pilot programme on a clinical compound bank for repurposing This programme includes the following topics: cardiovascular diseases and diabetes; respiratory diseases; neurodegenerative diseases; rare/orphan diseases